SGM
MRTX

Skye Global Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Skye Global Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,400
Closed -$711K – 78
2021
Q2 		$711K Hold
4,400
– – 0.01% 54
2021
Q1 		$754K Buy
+4,400
New +$754K 0.01% 51